14th feruary, 2025 has considered and approved unaudited financial results of the company for the Third quarter ended 31st December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Agrigenetics Limited reported nil revenue from operations in Q3 FY26, compared to Rs 3.37 lakhs in Q3 FY25, reflecting continued weakness in its agricultural seeds trading business. The company swung to a loss of Rs 4.40 lakhs in the quarter, against a profit of Rs 2.47 lakhs in the year-ago period, with total revenue falling to Rs 19.78 lakhs from Rs 27.81 lakhs. For the nine months ended December 2025, profit after tax stood at Rs 54.64 lakhs (vs Rs 21.11 lakhs last year), but this was driven almost entirely by non-core income such as interest (Rs 66.73 lakhs) and changes in investment values rather than actual business activity. The statutory auditor issued a clean (unqualified) Limited Review Report with no qualifications or concerns raised.
Shareholders should note that the company's core agricultural seeds trading segment has produced no operational revenue this quarter, raising sustainability concerns even though investment and interest income currently keep the bottom line positive. The shift to a quarterly loss and absence of core earnings may weigh on the stock in the near term.